Showing 301 - 320 results of 2,192 for search '"Comorbidity', query time: 0.08s Refine Results
  1. 301
  2. 302
  3. 303
  4. 304
  5. 305

    Prescription pattern, glycemic control status, and predictors of poor glycemic control among diabetic patients with comorbid chronic kidney disease in Ethiopia: a facility-based cross-sectional study by Oumer Sada Muhammed, Minimize Hassen, Samuel Mamusha

    Published 2025-02-01
    “…Objective This study aimed to assess prescription patterns, glycemic control status, and the contributing factors to poor glycemic control among diabetic patients with comorbid chronic kidney disease at Tikur Anbessa Specialized Hospital, Ethiopia. …”
    Get full text
    Article
  6. 306
  7. 307
  8. 308
  9. 309

    Multiple Comorbidities, Psychiatric Disorders, Healthcare Resource Utilization and Costs Among Adults with Essential Tremor: A Retrospective Observational Study in a Large US Commercially Insured and Medicare Advantage Population by Dingwei Dai, Ali Samiian, Joaquim Fernandes, Henriette Coetzer

    Published 2022-08-01
    “…**Objectives:** To assess comorbidities, psychiatric disorders, healthcare resource utilization (HCRU), and costs among patients with ET compared with patients without ET. …”
    Get full text
    Article
  10. 310

    Does semaglutide reduce alcohol intake in Danish patients with alcohol use disorder and comorbid obesity? Trial protocol of a randomised, double-blinded, placebo-controlled clinical trial (the SEMALCO trial) by Jens Juul Holst, Tina Vilsbøll, Claus Thorn Ekstrøm, Helene Benveniste, Nora D Volkow, Anders Fink-Jensen, Gitte M Knudsen, Mette Kruse Klausen, Tugba Kuzey, Julie Niemann Pedersen, Signe Keller Justesen, Line Rasmussen, Ulla B Knorr, Graeme Mason, George Koob

    Published 2025-01-01
    “…Glucagon-like peptide-1 (GLP-1) receptor agonists have shown promising effects in reducing alcohol consumption in preclinical experiments, and clinical trials are in high demand to investigate these potentially beneficial effects in patients diagnosed with AUD.Methods and analysis The effects of the once-weekly GLP-1 receptor agonist semaglutide will be investigated in a 26-week, randomised, placebo-controlled, double-blinded clinical trial. 108 patients diagnosed with AUD and comorbid obesity (body mass index (BMI)≥30 kg/m2)) will be randomised to treatment with either semaglutide or placebo in combination with cognitive behavioural therapy. …”
    Get full text
    Article
  11. 311

    Modular-based psychotherapy (MoBa) versus cognitive–behavioural therapy (CBT) for patients with depression, comorbidities and a history of childhood maltreatment: study protocol for a randomised controlled feasibility trial by Elisabeth Schramm, Martin Hautzinger, Carolin Jenkner, Moritz Elsaesser, Sabine Herpertz, Hannah Piosczyk

    Published 2022-07-01
    “…Major reasons for individual non-response are interindividual heterogeneity of etiological mechanisms and pathological forms, and a high rate of comorbid disorders. Personalised treatments targeting comorbidities as well as underlying transdiagnostic mechanisms and factors like early childhood maltreatment may lead to better outcomes. …”
    Get full text
    Article
  12. 312
  13. 313

    THE COURSE OF ACUTE RESPIRATORY COVID-19 DISEASE, COMPLICATED BY COMMUNITY-ACQUIRED PNEUMONIA AGAINST THE BACKGROUND OF THE CARDIOVASCULAR SYSTEM PATHOLOGY by T.A. Trybrat, Yu.M Kazakov, O.O. Honcharova, S.V Shut, V.D. Sakevich

    Published 2021-08-01
    Subjects: “…course, acute respiratory covid-19 disease, complications, community-acquired pneumonia, comorbidity, pathology of the cardiovascular system.…”
    Get full text
    Article
  14. 314
  15. 315
  16. 316
  17. 317
  18. 318
  19. 319
  20. 320